Login
$CCCC
$2.63 -$0.02 (0.75%) After hours

Company Executives

Officer Age In this role 2025 pay Source
Andrew J. Hirsch Also a director
President & CEO
Title from the Form 4 dated Feb 13, 2026
55 Not stated $2,940,975
Kendra R. Adams
Chief Financial Officer, Head of Corporate Affairs and Treasurer
49 Since 2026
this year
$1,476,789
Scott N. Boyle
Chief Business Officer
48 Since 2022
4 years
Not reported
Paige Mahaney
Chief Scientific Officer
56 Since 2024
2 years
Not reported
Leonard Reyno
Chief Medical Officer
64 Since 2023
3 years
$1,641,798
Kelly A. Schick
Chief People Officer
46 Since 2021
5 years
Not reported

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Directors
9
serving now
Independent
5 of 5
stated in the proxy; 4 not stated
Average tenure
4.2 years
from year joined
CEO also chairs the board
No
Ronald Harold Wilfred Cooper
Director Age On board Independent Committees Other public boards 2025 pay Source
Ronald Harold Wilfred Cooper
63 2024
2 years
Independent None stated enGene Holdings, Inc. $119,249
Andrew J. Hirsch
55 2020
6 years
Not stated None stated Editas Medicine, Inc. Paid as CEO
Utpal Koppikar
55 2022
4 years
Independent None stated None stated $100,499
Stephen Fawell, Ph.D.
66 2024
2 years
Not stated
Science and Technology Committee
None stated $85,499
Kenneth C. Anderson, M.D.
74 2015
11 years
Not stated
Science and Technology Committee
None stated $85,499
Laura Bessen, M.D.
63 2022
4 years
Not stated
Science and Technology Committee
None stated $90,249
Owen Hughes
51 2023
3 years
Independent None stated Xoma Royalty Corp $89,958
Donna Grogan, M.D.
69 2022
4 years
Independent None stated None stated $96,999
Steven Hoerter
55 2024
2 years
Independent None stated MBX Biosciences, Inc., Oric Pharmaceuticals, Inc. Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 29, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support